Immunotherapy Biomarkers

Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study
Guanchao Ye, Guangyao Wu, Yu Qi, Kuo Li, Mingliang Wang, Chunyang Zhang, Feng Li, Leonard Wee, Andre Dekker, Chu Han, Zaiyi Liu, Yongde Liao, Zhenwei Shi

Journal for ImmunoTherapy of Cancer Sep 2024, 12 (9) e009348; DOI: 10.1136/jitc-2024-009348
Tumor microenvironment biomarkers predicting pathological response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma: post-hoc analysis of a single center, phase 2 study
Tingting Feng, Qian Li, Rui Zhu, Chang Yu, Liwei Xu, Lisha Ying, Canming Wang, Weiming Xu, Jinchao Wang, Jing Zhu, Minran Huang, Chenyang Xu, Jiaoyue Jin, Xiaotian Zhang, Tingting Lu, Ying Yang, Changbin Zhu, Qixun Chen, Dan Su

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e008942; DOI: 10.1136/jitc-2024-008942
Targeting Gsk3a reverses immune evasion to enhance immunotherapy in hepatocellular carcinoma
Xin Zheng, Luyu Yang, Xiaotian Shen, Junjie Pan, Yiran Chen, Jixuan Chen, Hao Wang, Jiaqi Meng, Zhenchao Chen, Sunzhe Xie, Yitong Li, Bolun Zhu, Wenwei Zhu, Lunxiu Qin, Lu Lu

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e009642; DOI: 10.1136/jitc-2024-009642
Gene panel predicts neoadjuvant chemoimmunotherapy response and benefit from immunotherapy in HER2-negative breast cancer
Xunxi Lu, Zongchao Gou, Hong Chen, Li Li, Fei Chen, Chunjuan Bao, Hong Bu

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e009587; DOI: 10.1136/jitc-2024-009587
Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy
Motoki Nakamura, Tetsuya Magara, Maki Yoshimitsu, Shinji Kano, Hiroshi Kato, Keisuke Yokota, Katsuhiro Okuda, Akimichi Morita

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008441; DOI: 10.1136/jitc-2023-008441
NAD⁺ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer
Meihua Yang, Bo Wang, Weibin Hou, Honghui Zeng, Wang He, Xin-Ke Zhang, Dong Yan, Hao Yu, Long Huang, Lu Pei, Kaiwen Li, Haide Qin, Tianxin Lin, Jian Huang

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009281; DOI: 10.1136/jitc-2024-009281
Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis
Yuan-Yuan Zhao, Zhen Fan, Bao-Rui Tao, Zun-Guo Du, Zhi-Feng Shi

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009232; DOI: 10.1136/jitc-2024-009232
ImmunoPET imaging of LAG-3 expression in tumor microenvironment with ⁶⁸Ga-labelled cyclic peptides tracers: from bench to bedside
Ming Zhou, Bei Chen, Chenxi Lu, Jinhui Yang, Peng Liu, Xiaobo Wang, Shuo Hu

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009153; DOI: 10.1136/jitc-2024-009153
Impact of LAG-3/FGL1 pathway on immune evasive contexture and clinical outcomes in advanced urothelial carcinoma
Takashi Yoshida, Takahiro Nakamoto, Naho Atsumi, Chisato Ohe, Takeshi Sano, Yoshiki Yasukochi, Koji Tsuta, Hidefumi Kinoshita

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009358; DOI: 10.1136/jitc-2024-009358
Peptide-based PET tracer targeting LAG-3 for evaluating the efficacy of immunotherapy in melanoma
Peizhe Yuan, Yu Long, Nannan Wei, Yan Wang, Ziyang Zhu, Jinquan Han, Dawei Jiang, Xiaoli Lan, Yongkang Gai

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009010; DOI: 10.1136/jitc-2024-009010

Main menu

Immunotherapy Biomarkers

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunotherapy Biomarkers

Pages